These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9601665)

  • 41. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report].
    Hanihara T; Kubota H; Amano N; Yamaoka K; Yagishita S
    No To Shinkei; 1994 May; 46(5):487-92. PubMed ID: 8060688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy.
    Takahashi M; Weidenheim KM; Dickson DW; Ksiezak-Reding H
    J Neuropathol Exp Neurol; 2002 Jan; 61(1):33-45. PubMed ID: 11829342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case.
    Mochizuki A; Ueda Y; Komatsuzaki Y; Tsuchiya K; Arai T; Shoji S
    Acta Neuropathol; 2003 Jun; 105(6):610-4. PubMed ID: 12669238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration.
    Kasashima S; Oda Y
    Acta Neuropathol; 2003 Feb; 105(2):117-24. PubMed ID: 12536222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease.
    Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ
    Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration.
    Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H
    Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy.
    Zemaitaitis MO; Kim SY; Halverson RA; Troncoso JC; Lee JM; Muma NA
    J Neuropathol Exp Neurol; 2003 Feb; 62(2):173-84. PubMed ID: 12578227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bcl-2 and Bax proteins in Lewy bodies from patients with Parkinson's disease and Diffuse Lewy body disease.
    Tortosa A; López E; Ferrer I
    Neurosci Lett; 1997 Nov; 238(1-2):78-80. PubMed ID: 9464659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy.
    Armstrong RA; Lantos PL; Cairns NJ
    Parkinsonism Relat Disord; 2007 Feb; 13(1):50-4. PubMed ID: 17046313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical study of A2B5-positive ganglioside in postmortem human brain tissue of Alzheimer disease, amyotrophic lateral sclerosis, progressive supranuclear palsy and control cases.
    Tooyama I; Yamada T; Kim SU; McGeer PL
    Neurosci Lett; 1992 Feb; 136(1):91-4. PubMed ID: 1321969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased bcl-2/bax ratio in B-cell chronic lymphocytic leukemia is associated with a progressive pattern of disease.
    Molica S; Dattilo A; Giulino C; Levato D; Levato L
    Haematologica; 1998 Dec; 83(12):1122-4. PubMed ID: 9949631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of Bax and Bcl-2 in apoptosis after experimental traumatic brain injury in the rat.
    Wennersten A; Holmin S; Mathiesen T
    Acta Neuropathol; 2003 Mar; 105(3):281-8. PubMed ID: 12557016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human Meissner corpuscles express Bcl-2 but not Bax protein.
    Ortiz-Rey JA; Alvarez-Alvarez C; Antón-Badiola I; San Miguel-Fraile P; De la Fuente-Buceta A
    Neurosci Lett; 2002 Aug; 329(2):240-2. PubMed ID: 12165421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [An autopsy case of postencephalitic parkinsonism: investigation on neurofibrillary tangles in comparison with those in progressive supranuclear palsy].
    Mori H; Yoshimura M; Mizutani T; Kuzuhara S; Yamanouchi H; Shimada H; Tomonaga M
    No To Shinkei; 1990 Jun; 42(6):553-9. PubMed ID: 2169789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX.
    Uchihara T; Endo K; Kondo H; Okabayashi S; Shimozawa N; Yasutomi Y; Adachi E; Kimura N
    Acta Neuropathol Commun; 2016 Nov; 4(1):118. PubMed ID: 27842611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.
    Mott RT; Dickson DW; Trojanowski JQ; Zhukareva V; Lee VM; Forman M; Van Deerlin V; Ervin JF; Wang DS; Schmechel DE; Hulette CM
    J Neuropathol Exp Neurol; 2005 May; 64(5):420-8. PubMed ID: 15892300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphorylation and cleavage of tau in non-AD tauopathies.
    Guillozet-Bongaarts AL; Glajch KE; Libson EG; Cahill ME; Bigio E; Berry RW; Binder LI
    Acta Neuropathol; 2007 May; 113(5):513-20. PubMed ID: 17357802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.